winph4 STRATA Skin Sciences ( NASDAQ:SSKN – Get Free Report ) and Delcath Systems ( NASDAQ:DCTH – Get Free Report ) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Institutional and Insider Ownership 32.4% of STRATA Skin Sciences shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 39.0% of STRATA Skin Sciences shares are owned by company insiders. Comparatively, 17.9% of Delcath Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Volatility and Risk STRATA Skin Sciences has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Analyst Recommendations Delcath Systems has a consensus target price of $21.50, indicating a potential upside of 120.29%. Given Delcath Systems’ stronger consensus rating and higher probable upside, analysts plainly believe Delcath Systems is more favorable than STRATA Skin Sciences. Earnings & Valuation This table compares STRATA Skin Sciences and Delcath Systems”s gross revenue, earnings per share and valuation. STRATA Skin Sciences has higher revenue and earnings than Delcath Systems. Delcath Systems is trading at a lower price-to-earnings ratio than STRATA Skin Sciences, indicating that it is currently the more affordable of the two stocks. Profitability This table compares STRATA Skin Sciences and Delcath Systems’ net margins, return on equity and return on assets. Summary STRATA Skin Sciences beats Delcath Systems on 8 of the 14 factors compared between the two stocks. About STRATA Skin Sciences ( Get Free Report ) STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. About Delcath Systems ( Get Free Report ) Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter .

Newsmakers for November 24Greenland Leader Delivers Forceful Rejection of Trump Take Over Attempt: 'Greenland Belongs to the People of Greenland'Medtronic (NYSE:MDT) Given New $97.00 Price Target at Sanford C. Bernstein

Only outdoor animals use straw as beddingYagi Studio/DigitalVision via Getty Images The Avantis U.S. Small Cap Value ETF ( NYSEARCA: AVUV ) is one of the best-performing U.S. value ETFs in the market, significantly outperforming small-cap and value benchmarks, and even slightly outperforming the S&P 500. Performance has ramped up as At the CEF/ETF Income Laboratory , we manage closed-end fund (CEF) and exchange-traded fund (ETF) portfolios targeting safe and reliable ~8% yields to make income investing easy for you. Check out what our members have to say about our service. To see all that our exclusive membership has to offer, sign up for a free trial by clicking on the button below! Juan de la Hoz has worked as a fixed income trader, financial analyst, operations analyst, and as an economics professor. He has experience analyzing, trading, and negotiating fixed-income securities, including bonds, money markets, and interbank trade financing, across markets and currencies. He focuses on dividend, bond, and income funds, with a strong focus on ETFs. Juan is a contributor to the investing group CEF/ETF Income Laboratory which is led by Stanford Chemist. Features of the service include: managed income portfolios (targeting safe and reliable ~8% yields) making use of high-yield opportunities in the CEF and ETF fund space. These are geared toward both active and passive investors of all experience levels. The vast majority of CEF/ETF Income Laboratory holdings are also monthly-payers, for faster compounding and steady income streams. Other features include 24/7 chat, and trade alerts. Learn More . Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.Shares of Matthews International Co. ( NASDAQ:MATW – Get Free Report ) gapped up prior to trading on Friday . The stock had previously closed at $25.49, but opened at $29.75. Matthews International shares last traded at $31.11, with a volume of 113,004 shares. Analysts Set New Price Targets Separately, B. Riley dropped their price target on Matthews International from $54.00 to $40.00 and set a “buy” rating for the company in a research note on Thursday, September 26th. Get Our Latest Research Report on Matthews International Matthews International Stock Up 21.0 % Matthews International Increases Dividend The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Monday, December 2nd will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 3.24%. This is a boost from Matthews International’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Monday, December 2nd. Matthews International’s dividend payout ratio is -49.74%. Institutional Trading of Matthews International Hedge funds have recently modified their holdings of the company. Allspring Global Investments Holdings LLC raised its holdings in shares of Matthews International by 8.5% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 708,352 shares of the company’s stock worth $16,434,000 after acquiring an additional 55,687 shares in the last quarter. Barington Capital Group L.P. raised its holdings in shares of Matthews International by 18.1% during the 2nd quarter. Barington Capital Group L.P. now owns 385,000 shares of the company’s stock worth $9,644,000 after acquiring an additional 59,000 shares in the last quarter. AQR Capital Management LLC raised its holdings in shares of Matthews International by 136.2% during the 2nd quarter. AQR Capital Management LLC now owns 23,239 shares of the company’s stock worth $582,000 after acquiring an additional 13,399 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Matthews International by 1.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 68,771 shares of the company’s stock valued at $2,138,000 after buying an additional 1,063 shares during the period. Finally, Comerica Bank raised its holdings in Matthews International by 73.9% during the 1st quarter. Comerica Bank now owns 24,246 shares of the company’s stock valued at $754,000 after buying an additional 10,304 shares during the period. 83.08% of the stock is owned by hedge funds and other institutional investors. Matthews International Company Profile ( Get Free Report ) Matthews International Corporation provides brand solutions, memorialization products, and industrial technologies worldwide. It operates through three segments: Memorialization, Industrial Technologies, and SGK Brand Solutions. The Memorialization segment provides bronze and granite memorials, upright granite memorials and monuments, concrete burial vaults, cremation memorialization products, granite benches, flower vases, crypt plates and letters, cremation urns, niche units, cemetery features, and statues, as well as bronze plaques, letters, emblems, vases, lights and photo ceramics, granite monuments, mausoleums, crypts, and flush memorials. Recommended Stories Receive News & Ratings for Matthews International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matthews International and related companies with MarketBeat.com's FREE daily email newsletter .

Landlord group wins big as AP calls Prop 34, the ballot measure it funded to block political spending by the LA-based AIDS Healthcare Foundation, which bankrolled three statewide rent control measures. Alameda County district attorney finally concedes defeat after her landslide loss in a recall election less than two years into her first term, the latest victim of a voter backlash against liberal crime policies. Centrist Democrat, heir to Levi’s fortune and new San Francisco mayor picks transition team and takes office in 6 weeks. But winning elections may be easier than cleaning up crime and homeless encampments.Conference title games a chance at a banner, bragging rights and, for some, a season-wrecking loss